Pages that link to "Q1129105"
Jump to navigation
Jump to search
The following pages link to diabetic nephropathy (Q1129105):
Displayed 50 items.
- Benigno Aquino III (Q1464) (← links)
- diabetes (Q12206) (← links)
- gabapentin (Q410352) (← links)
- pregabalin (Q412174) (← links)
- (Q3347170) (redirect page) (← links)
- formication (Q5470185) (← links)
- diabetic glomerulosclerosis (Q5881174) (← links)
- ACE (Q14863991) (← links)
- COL3A1 (Q14906847) (← links)
- (Q18971605) (redirect page) (← links)
- (Q18975074) (redirect page) (← links)
- Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy (Q22254569) (← links)
- Genetic and functional effects of membrane metalloendopeptidase on diabetic nephropathy development (Q24294603) (← links)
- miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy (Q24298641) (← links)
- Cloning of a novel gene in the human kidney homologous to rat munc13s: its potential role in diabetic nephropathy (Q24320538) (← links)
- Insulin receptor substrate-2 is expressed in kidney epithelium and up-regulated in diabetic nephropathy (Q24338974) (← links)
- Growth hormone (GH)-dependent expression of a natural antisense transcript induces zinc finger E-box-binding homeobox 2 (ZEB2) in the glomerular podocyte: a novel action of gh with implications for the pathogenesis of diabetic nephropathy (Q24634127) (← links)
- Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy (Q24657470) (← links)
- Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy (Q24682750) (← links)
- Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy (Q24794548) (← links)
- Losartan and diabetic nephropathy: commentaries on the RENAAL study (Q24796010) (← links)
- Apolipoprotein E gene polymorphism is not a strong risk factor for diabetic nephropathy and retinopathy in Type I diabetes: case-control study (Q24801926) (← links)
- Smoking, oxidative stress and inflammation: impact on resting energy expenditure in diabetic nephropathy (Q24815199) (← links)
- Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy (Q26740305) (← links)
- Recent Progress in Stem Cell Therapy for Diabetic Nephropathy (Q26740433) (← links)
- Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease (Q26741451) (← links)
- Current Challenges in Diabetic Nephropathy: Early Diagnosis and Ways to Improve Outcomes (Q26744419) (← links)
- Histone Acetylation and Its Modifiers in the Pathogenesis of Diabetic Nephropathy (Q26744442) (← links)
- Adenosine monophosphate-activated protein kinase in diabetic nephropathy (Q26745623) (← links)
- Recent advances in managing and understanding diabetic nephropathy (Q26745900) (← links)
- Urinary Markers of Tubular Injury in Early Diabetic Nephropathy (Q26746921) (← links)
- Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease (Q26747131) (← links)
- Angiopoietins and diabetic nephropathy (Q26747192) (← links)
- Novel anti-inflammatory drugs for the treatment of diabetic kidney disease (Q26747412) (← links)
- Role of mTOR Inhibitors in Kidney Disease (Q26747506) (← links)
- Clinical Predictive Factors in Diabetic Kidney Disease Progression (Q26749494) (← links)
- Liuwei Dihuang Pills Enhance the Effect of Western Medicine in Treating Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials (Q26753148) (← links)
- MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy (Q26766102) (← links)
- Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control (Q26766259) (← links)
- Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials (Q26766599) (← links)
- Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials (Q26768469) (← links)
- A Systems Biology Overview on Human Diabetic Nephropathy: From Genetic Susceptibility to Post-Transcriptional and Post-Translational Modifications (Q26769678) (← links)
- Drug Targets for Oxidative Podocyte Injury in Diabetic Nephropathy (Q26769787) (← links)
- Autophagy: A Novel Therapeutic Target for Diabetic Nephropathy (Q26771919) (← links)
- Immune Cells and Inflammation in Diabetic Nephropathy (Q26772998) (← links)
- Histological changes of kidney in diabetic nephropathy (Q26773633) (← links)
- An Update on the Use of Animal Models in Diabetic Nephropathy Research (Q26774178) (← links)
- Redox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and Podocytes (Q26778527) (← links)
- Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction? (Q26782283) (← links)
- Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy (Q26784039) (← links)